Advertisement

Topics

Companies Related to "TRK1Transforming Tyrosine Kinase TrkA High Affinity Nerve Growth" [Most Relevant Company Matches] RSS

11:11 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "TRK1Transforming Tyrosine Kinase TrkA High Affinity Nerve Growth" found in our extensive corporate database of over 50,000 company records.

Showing "TRK1Transforming Tyrosine Kinase TrkA High Affinity Nerve Growth" Companies 1–25 of 5,700+

Extremely Relevant

SGX Pharmaceuticals, Inc.

SGX Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development and commercialization of novel, targeted therapeutics directed at addressing unmet medical needs in oncology. Our drug development programs target the MET receptor tyrosine kinase, an enzyme implicated in a broad array of cancers, and the BCR-ABL tyrosine kinase enzyme for the treatment of Chronic Myelog...


Relevant

ArQule, Inc.

ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company’s targeted, broad-spectrum products and research programs are focused on key biological processes that are central to human cancers. ArQule’s lead product, in Phase 2 clinical development, is ARQ 197, an in...

Tyrosine Pharma, Inc.

Tyrosine Pharma, Inc., is a New Mexico-based biotech start-up company and a New Mexico Angels Technology Showcase Company. Visit www.tyrosinepharma.com for additional information.


Apex Affinity

Apex Affinity provides innovative services that help organizations reach new customers, increase satisfaction and loyalty, and create new revenue streams. From traditional retail discount cards to the latest e-marketing technologies, Apex enables affinity groups to engage their members, offer high-value services, and grow. For more information, visit www.a...

GloboZymes

GloboZymes is a leading provider of top quality signal transduction enzymes, proteins and antibodies.We maintain a cell signaling, cancer and apoptosis-related research program. Our purified protein kinase, protein phosphatase, protein kinase substrate, modulator protein, protein synthesis initiation factor and affinity-purified antibody preparations generally exhibit greater than 90% homogeneity ...

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals is focused on neurodegenerative diseases that affect millions of patients worldwide. The company’s novel lead candidate NB-01 is a potential treatment for diabetic neuropathic pain. NB-01 increases levels of the neurotrophin, nerve growth factor (NGF). NGF inhibits nerve cell death and promotes nerve regeneration. The compound...

Affinity Growth Advisors

Affinity Growth Advisors is a leading New York-based investor relations and public relations consultancy. The partners and principals of the firm are senior level professionals with Wall Street backgrounds who have extensive capital markets knowledge and deep, broad-based relationships amongst the investment community. The firm has advised clients on a ran...

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those ...

Affinity Health Plan

Founded in 1986, Affinity is an independent, not-for-profit organization driven by the mission to help its members and their families and communities lead healthier lives. For over 30 years, Affinity has built one of the area’s largest physician networks, which includes 40,000 providers and more than 85 of the top hospitals in the Greater New York reg...

Trophogen, Inc

Trophogen, Inc. is a biotechnology company founded in 2001 with series A funding from Toucan Capital, focusing on the development of high affinity glycoprotein hormone and related growth factor analogs for targeted therapy and imaging of ovarian, breast, prostate, testicular and thyroid cancers as well as for human and animal infertility.

AIMM Therapeutics B.V.

AIMM Therapeutics (AIMM) is a leading antibody company that based on its synergistic, state-of-the-art antibody technology platform develops high affinity human monoclonal antibodies from immortalized and selected B cells of individuals who produce antibodies with high therapeutic value. AIMM antibodies can be further affinity matured in a proprietary process ...

NERVANA, LLC

NERVANA was created by two brothers, Drs. Richard and Daniel Cartledge, both practicing physicians, who have been fascinated by Vagus nerve stimulation for decades. They had an idea to take the best part of vagus nerve stimulation and provide it to users in a way that was easy to use. In 2014, they formed NERVANA LLC, including medical and intellectual pro...

AIMM Therapeutics

AIMM Therapeutics (AIMM) is a leading antibody company that based on its synergistic, state-of-the-art antibody technology platform develops high affinity human monoclonal antibodies from immortalized and selected B cells of individuals who produce antibodies with high therapeutic value. AIMM antibodies can be further affinity matured in a proprietary process ...

Affinity Biologicals Inc

Affinity Biologicals Inc. (ABI) is now in it’s sixteenth year as a manufacturer of antibodies and antibody-related products for use in thrombosis and haemostasis research as well as medical diagnostics manufacturing. ABI has a quality system certified to ISO-13485 standards and is USFDA-QSR compliant. Our product line consists of more than 200 antibody products, matched-pair antibody sets for EL...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix’s lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular ...

Ziarco

Ziarco is a clinical-stage biotechnology company developing innovative therapeutics targeting inflammatory and allergic diseases. The company’s product pipeline includes ZPL-3893787, an H4 receptor antagonist that has completed a Phase 1 multiple ascending dose study. A second clinical-stage, programme targets inflammatory disorders by inhibiting cyto...

Ambit Biosciences Corporation

Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit employs a novel and proprietary kinase profiling technology, KINOMEscan(TM), to screen compounds against 442 human kinases.

CatchMabs BV

CatchMabs develops the iMab® technology (industrial Molecular affinity bodies), small designer proteins that can bind target molecules with both high affinity and high specificity, thus providing a single step purification for large scale processes in pharma and food processing industries. iMabs can be optimized to fit particular process conditions and be re-used after recovery of the captured ta...

NeuroMetrix

NeuroMetrix, Inc. was founded in June 1996 as a spin-off from the Harvard-M.I.T. Division of Health Sciences and Technology. The Company’s mission is to: Create value for our customers by developing innovative neurological diagnostic and therapeutic solutions that maximize quality of care and economic outcomes Produce a superior return on investment for our shareholders Provide our employees...

The Yield Growth Corp.

The Yield Growth Corp. is an asset growth company cultivating high value companies and brands centered around the legal cannabis industry.

Biogenic Animal Model for Chronic Pain (TM)

NeuroDigm offers an animal model for neurogenic persistent pain based on tissue repair and neural regeneration, not nerve damage as in current models. Using clinical concepts NeuroDigm has developed a percutaneous method for applying a gel to a peripheral nerve causing pain lasting up to a year.

Cellzome Inc.

Cellzome is a privately-owned drug discovery and development company identifying a new generation of kinase-targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads(TM), a proprietary technology for the screening and profiling of kinase inhibitors in physiologically-relevant cells and tissues. The most advanced program, targeting PI3K(ga...

CellPro Incorporated

CellPro Incorporated has developed a unique monoclonal antibody-based system that can be used to separate specificcells from complex cell mixtures for use in a wide range of therapeutic, diagnostic and research applications. The CellPro technology selects cells in a continuous flow system by using a high affinity avidin-biotin binding process. As a result, it combines high levels of throughput wit...

Affinity Biologicals Incorporated

Affinity Biologicals Inc. is a manufacturer producing antibodies and antibody-related reagents and plasmas used in thrombosis and hemostasis research and in medical diagnostics manufacturing. A primary manufacturer of quality antibodies and plasmas.

NeuroDigm

NeuroDigm Co. is helping companies solve the puzzle of chronic pain with the Hot Spot ModelTM of Neuropathic Pain. This is THE Alternative, Nonsurgical Model to create neuropathic pain as found in humans. The Hot Spot Model uses a gentle percutaneous procedure with a biocompatible gel to gradually over time create chronic neuropathic pain. Known pain behaviors are created without the use of o...


More From BioPortfolio on "TRK1Transforming Tyrosine Kinase TrkA High Affinity Nerve Growth"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks